Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Tian-Liang XiaShu-Mei YanLi YuanMu-Sheng Zeng

Published in: Cancer management and research (2020)

Our results revealed that the METTL3 expression level could be used as an independent prognostic biomarker for ESCC prognosis.

Keyphrases